vTv Therapeutics Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging +0.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.75 | $-1.05 | -40.0% | Miss | |
| Q1 FY26 | not reported | $1.65 | not reported | not reported | |
| Q4 FY25 | $-0.98 | $-0.58 | +40.8% | Beat |
Back to VTVT overview · VTVT holders · VTVT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.